CVRx, Inc.

Stage 4 · Declining · week 22

As of Oct 22, 2026, CVRx is in Stage 4, the downtrend phase, now in week 22 (since May 20, 2026). It closed at $1.37, 87.3% below its 52-week high and below its 200-day average, which is falling.

$1.37

+0.00% today

$36.5M · Micro cap

Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Steady

Edge

—

Is CVRX early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…

Stage Cycle Timeline2023-08-16 → 2026-10-22

S2 14w

S4 15w

S1 16w

S4 22w

2023-08-162026-10-22

S1S2S3S4Setup score (0–10, dashed line at 5)

S2 7w → S3 7w → S2 14w → S3 7w → S4 15w → S1 4w → S4 8w → S1 5w → S2 13w → S3 7w → S4 13w → S1 16w → S2 7w → S3 5w → S4 6w → S1 7w → S2 1w → S1 2w → S4 22w current

Total tracked: 166 weeks across 19 stage runs.

CVRX among Medical Devices113th of 141 by relative strength

All 141 →

Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#	Stock	Stage	RS	1M
1	TXG10x Genomics, Inc.	Stage 2 · wk 48	99	−7.8%
2	RCELAvita Medical, Inc.	Stage 2 · wk 13	98	+40.8%
3	BFLYButterfly Network, Inc. Class A	Stage 2 · wk 26	98	−26.0%
4	HAEHaemonetics Corporation	Stage 2 · wk 17	96	+8.7%
5	GKOSGlaukos Corporation	Stage 2 · wk 25	96	+15.1%
6	AXGNAxogen, Inc.	Stage 3 · wk 2	95	−15.3%
7	NEOGNeogen Corporation	Stage 2 · wk 14	95	−11.7%
8	BVSBioventus Inc. Class A	Stage 2 · wk 15	95	+10.5%
…113	CVRXCVRx, Inc.	Stage 4 · wk 22	9	−49.6%

vs 52W High

-87.3%

$1.30 lo$10.81 hi

87.3% below 52W high, deep Stage 4 damage

In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.

Stage Maturity

Week 22

1w13w26w

Week 22, extended decline

How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.

vs 200 DMA

-74.9%

200 DMA: $5.46 · sloping down

In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.

Rel Volume

0.33x

vs 50-day avg

High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.

Trend Health

↓

Short-term trend rolling over

Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.

-49.6%

-71.1%

-82.1%

YTD

-80.7%

-86.4%

Scan Membership

Breakout Watch

Latest: 2024-12-06

4 appearances in last 60 days. First seen: 2022-09-12.

A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.

Recent Stage Timeline

2026-10-22S4

Wk 22 · Vol 0.33x

2026-10-21S4

Wk 22 · Vol 0.33x

2026-10-20S4

Wk 22 · Vol 0.35x

2026-10-19S4

Wk 21 · Vol 0.31x

2026-10-16S4

Wk 21 · Vol 0.33x

2026-10-15S4

Wk 21 · Vol 0.31x

2026-10-14S4

Wk 21 · Vol 0.79x

2026-10-13S4

Wk 21 · Vol 0.44x

2026-10-12S4

Wk 20 · Vol 0.42x

2026-10-09S4

Wk 20 · Vol 0.36x

2026-10-08S4

Wk 20 · Vol 0.47x

2026-10-07S4

Wk 20 · Vol 0.82x

Moving averages & range

50 DMA

$2.44

200 DMA

$5.46

52W High

$10.81

52W Low

$1.30

5D Low

$1.30

Resistance levels (recent highs)

20d High

$2.70

60d High

$5.94

120d High

$7.80

250d High

$10.81

Next resistance

+97.1%

to 20d High

ROE

-133.4%

Profit margin -84.9%

Dividend Yield

0.00%

P/B 1.8

CVRx: quick answers

What stage is CVRx in?

As of Oct 22, 2026, CVRx (CVRX) is in Stage 4, the downtrend phase. It entered Stage 4 on May 20, 2026 and is in week 22. What the four stages mean

Is CVRx in an uptrend?

No. CVRx is in a Stage 4 downtrend. It trades 74.9% below its 200-day average, which is falling.

How far is CVRx from its 52-week high?

CVRx closed at $1.37 on Oct 22, 2026, 87.3% below its 52-week high of $10.81. Its 52-week low is $1.30.

How has CVRx performed over the past year?

As of Oct 22, 2026, CVRx is down 86.4% over the past year and down 80.7% so far in 2026.

Which sector and industry is CVRx in?

CVRx is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system. It sells its products through direct sales force, sales agents, and independent distributors. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.